Dr. LaFargue is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 S Henderson St Ste 300
Fort Worth, TX 76104Phone+1 817-413-1500Fax+1 817-413-1499
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2017
- University of California (Irvine)Residency, Obstetrics and Gynecology, 2013 - 2017
- New York Medical CollegeClass of 2013
Certifications & Licensure
- CA State Medical License 2015 - 2026
- TX State Medical License 2019 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen
Nature Communications. 2023-04-26 - 3 citationsClinical analysis of pathologic complete responders in advanced-stage ovarian cancer.Christopher J LaFargue, Katelyn F Handley, Nicole D Fleming, Alpa M Nick, Anca Chelariu-Raicu
Gynecologic Oncology. 2022-04-01 - 24 citationsCD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance.Shaolin Ma, Lingegowda S. Mangala, W. Hu, Emine Bayaktar, Akira Yokoi
Cell Reports. 2021-08-17
Press Mentions
- Meet Our Newest Gynecologic Oncologist, Dr. Christopher LaFargueSeptember 17th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: